Blockade of receptors for the excitatory
neurotransmitter glutamate ameliorates neurological clinical signs in models of the CNS inflammatory
demyelinating disease multiple sclerosis (MS). To investigate whether
glutamate excitoxicity may play a role in MS pathogenesis, the cellular localization of
glutamate and its receptors, transporters and
enzymes was examined. Expression of
glutamate receptor (GluR) 1, a Ca(++)-permeable ionotropic
AMPA receptor subunit, was up-regulated on oligodendrocytes in active MS lesion borders, but Ca(++)-impermeable
AMPA GluR2 subunit levels were not increased. Reactive astrocytes in active plaques expressed
AMPA GluR3 and metabotropic
mGluR1, 2/3 and 5 receptors and the GLT-1 transporter, and a subpopulation was immunostained with
glutamate antibodies. Activated microglia and macrophages were immunopositive for GluR2, GluR4 and
NMDA receptor subunit 1.
Kainate receptor GluR5-7 immunostaining showed endothelial cells and dystrophic axons. Astrocyte and macrophage populations expressed
glutamate metabolizing
enzymes and unexpectedly the EAAC1 transporter, which may play a role in
glutamate uptake in lesions. Thus, reactive astrocytes in MS white matter lesions are equipped for a protective role in sequestering and metabolizing extracellular
glutamate. However, they may be unable to maintain
glutamate at levels low enough to protect oligodendrocytes rendered vulnerable to excitotoxic damage because of GluR1 up-regulation.